SlideShare uma empresa Scribd logo
1 de 27
Baixar para ler offline
PhUSE
                         Lisbon, Portugal – 8-10 October 2007



                         From Local Laboratory to
                         Standardisation and beyond:
                         Applying a commong
Early Drug Development
      In Oncology        grading system

                         Data Management Stream (DM01)


                         Angelo Tinazzi
                         Data Management and Programming Unit
                         SENDO Tech S.r.l. – Milan (ITALY)
                         co-authors
                         Irene Corradino, Enrica Paschetto, Sonia Colombini
SENDO (Southern Europe New Drug Organisation)

 Non profit Academic Research Organisation (ARO)
 Early Drug Development in Oncology
 Coordinating a Network of oncology-hospitals
   5 phase I (2 in Italy, 3 in Switzerland)
   ~ 30 phase II (Italy, Switzerland, Spain)
   Pre-clinical Laboratory (PK, PD)
   Head Quarter based in Milan
      Clinical Development
      Clinical Operations
      Data-Management
      Biostatistics
      Medical Writing



          Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
          beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   2
SENDO (Southern Europe New Drug Organisation) - Partners


                                       HQ-Activities
                                        Clinical development
                                         Clinical Operation
                                             Data Center
                                             Regulatory
                                                                                                 INT, Milano
                                              Monitoring
IOSI, Bellinzona,                                                                                Luca Gianni
                                               Logistic
 Cristiana Sessa
                                                      Core activities
                                                              Trial design
                                                       Selected Screening & MoA
                                                             Clinical trials
                                                           Pharmacokinetics
                                                          Pharmacodynamics




                                                     and also ....
                                         CHUV Lausanne, KSSG S Gallen,
                                         Istituto Mario Negri Milano

                    Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
                    beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   3
Previous Discuss at PhUSE about Lab Data Management

Szilagyi B, Binder C.
Complex Laboratory Data Management, Strategies
and Tools for a Way out of the Maze.
PhUSE 2005; DM05




          Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
          beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   4
Laboratory Data
 Use of Laboratory Tests in Clinical Trials
    For safety
    Activity
    Categories
      Pharmacodynamic
      Pharmacokynetic
      Microbiology
      Immunology
      Cytology
      Pharmacogenomic
 They are also used to make immediate clinical
 decision for patient’s care and to define the drug
 profile….focus on
    Haematology
    Chemistry
    Urinalysis

           Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
           beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   5
Laboratory Data Characteristics

  Qualitative vs Quantitative vs Semi-Quantitative
    Quantitative
       Most chemistry/hematology
       They are expressed in a specific unit
       They refere to a range (minimum-maximum)
    Semi-Quantitative (i.e. trace)
    Qualitative (i.e. +/-)
  Clinical Interpretation
    Not clinically significant
    Clinically Significant (Adverse Event)


           Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
           beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   6
Laboratory Data Characteristics
  Focus on hematology data
    White Blood Count (WBC)
      Hemoglobin
      Neutrophils
      Monocytes
      Basophils
      Eosinophils
      Band
      Lymphocytes
    Platelets
    Red Blood Cells
    Hematocrit
    Hemoglobin
    Coagulation tests (i.e. PTT, PT)

           Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
           beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   7
Laboratory Data Characteristics
  Focus on chemistry data
    Electrolytes
       Sodium
       Potassium
       Chloride
       Bicarbonate
       Carbon Dioxide

They maintain body fluid and blood pressure
essential for the function of most body systems




            Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
            beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   8
Laboratory Data Characteristics
  Focus on chemistry data
    Enzymes
       Aspartate Aminotransferase (AST/SGOT)
       Alanine Aminotransferase (ALT/SGPT)
       Gamma Glutamyl Transferase (γGT)
       Alkaline Phosphatase
       Troponin I
       Creatine Phosphokinase (CPK)
       Lactate Dehydrogenase (LDH)

They help diagnose liver and heart diseases




            Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
            beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   9
Laboratory Data Characteristics
  Focus on urinalysis data
      Protein
      Cells
      Hormone

They tests the health of organ and body process




          Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
          beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   10
Laboratory Data Characteristics
 Normal Ranges
  Normal ranges, or reference ranges, are used to determine if a
  person’s value is “normal”. The ‘normal range’ for a given
  constituent of clinical interest is considered to be the
  concentrations of the constituent which are found in the body
  fluid or excretions of a group of clinically normal persons.
    by gender
    by age
    fasting / non-fasting
    analysis method / kit used by laboratory may change over
     time, and so the normal ranges



           Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
           beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   11
Local Laboratory vs Central Laboratories

  Central Labs
Lab samples are analysed (and taken) in the same lab center
       Standard methods (and machine calibration)
       Unique normal ranges for each sample
       Electronic data transfer (no data-transcription errors)
  Local Labs
Lab samples are analysed (and taken) in different lab centers
       Sample can be taken anywhere / anytime
       Multiple normal ranges, so different methods applied
       No transport issue, but data need to re-keyed



            Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
            beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   12
Local laboratory data-management




         Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
         beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   13
Laboratory CRF – Option 1




                                            Normal Ranges and Unit
                                       Collected directly onto patient CRF




         Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
         beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   14
Laboratory CRF – Option 2




        120 0                                                                100 0            350 0



                     120 109/L (100-350)




         Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
         beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   15
The SENDO Experience with 4 Trials
 Study Nr        Nr. of                Nr. of samples               Nr. of                 Average Nr. of
                 Patients              collected                    Different              Local Labs Used
                                       (average nr by               Local                  by each
                                       Patient, min-max)            Labs Used              patient (min-max)
 1 (ph I)        34                    37 (2-90)                    44                     3.0 (1-7)
 2 (ph I)        32                    27 (2-79)                    33                     2.7 (1-6)
 3 (ph I)        20                    24 (2-61)                    31                     2.8 (1-5)
 4 (ph II)       38                    14 (2-33)                    11                     1.4 (1-3)
 Overall in                                                         97
 SENDO
 Repository



                                                                           High heterogeneity in
                                                                           unit reported (the example
                                                                           is for Platelets count only)




              Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
              beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   16
Quality Control
  Missing data (unit, range, interpretation)
  Hand writing legibility
  Unit and value incosistencies




  Normal Range Validity
  Outliers detection



          Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
          beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   17
Statistical Analysis Process

  Main Analysis
       Univariate (mean, std, min, max, etc)
       Shift Tables / Change From Baseline (absolute, %, log)
       Correlations
       Time to Event (i.e. Time to lowest observation, or time to nadir)
       Worst toxic effect observed


Data must be ‘manipulated’ so that results obtained
from different labs can be summed, weighted and
compared



            Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
            beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   18
Statistical Analysis Process
 Standardisation
Ensures that all laboratory values are expressed in the
same unit (Système International d’Unités - SI)

It consists in the adoption of a standard unit by applying
conversion factors

                                                                     Multiply 0.2558

  Potassium     13.7 mg/dL                  SI unit is mmol/L                             3.5 mmol/L




              Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
              beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   19
Statistical Analysis Process
  Normalisation                                                        5-29
                                                                      12-35
The application of a normalisation method to ensure                   10-45
homogenization of results obtained from different local               15-40
labs                                                                  12-30
                         U s − Ls             Reference/Standard Range
 s = Ls + ( x − L x )                                                  5
                        U x − Lx              Local Labs Range        10
        Observed Value                                                12
                                                                      12
The standard reference can be taken from the literature or from a sample of
                                                                      15
normal ranges by taking the 10°and the 90°percentiles                 29
                                                                      30
Assume an observed value of 10 measured in the lab with normal range 5-25, if
                                                                      35
our standard range has been determined to be 10-35…..
                                                                      40
                        35 − 10                                       45
 s = 10 + (10 − 5)                = 16.25             The normalised value
                                    −5
                               25 Normalization. Karvanen J. DIA, Vol. 37, pp. 101-107; 2004
The statistical basis of Laboratory
                  Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
                  beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   20
Applying a common grading system: the CTCAE
 NCI Common Terminology Criteria for Adverse
 Events – CTCAE (v3.0)
      A standard in oncology for classifying Adverse Events
      Severity
      A Grading system ranging from ‘0’ (no toxic effect) to ‘4’
      (severe toxic effect), with the addition of ‘5’ (death)
      An event has unique representation
      Events are organised in categories
      Link with MedDRA Term
 CTCAE Event Categories
 Allergy / Immunology                  Gastrointestinal                         Ocular / Visual
 Auditor / Ear                         Growth and Development                   Pain
 Blood / Bone Marrow                   Hemorrhage / Bleeding                    Pulmonary / Upper Respiratory
 Cardiac Arrhythmia                    Hepatobiliary / Pancreas                 Renal / Genitourinary
 Coagulation                           Infection                                Secondary Malignancy
 Constitutional Symptoms               Lymphatic                                Sexual / Reproductive Function
 Death                                 Metabolic / Laboratory                   Surgery / Intra-Operative Injury
 Dermatology / Skin                    Musculoskeletal / Soft Tissue            Syndromes
 Endocrine                             Neurology                                Vascular

                  Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
                  beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   21
Applying a common grading system: the CTCAE

Qualitative Definition (Arthritis)
 a grade 1 is defined as “Mild pain with inflammation, erythema, or
 joint swelling, but not interfering with function”
 a grade 4, is defined as “Disabling”

Quantitative Definition (Diarrhea)
 a grade 1, is defined as “Increase of <4 stools per day over baseline;
 mild increase in ostomy output compared to baseline”
 a grade 4, is defined….


Quantitative Definition based on Lab Data Results (Platelets Count)
Grade 1                  Grade 2                           Grade 3                           Grade 4
<LLN – 75,000/mm3        <75,000 – 50,000/mm3 <50,000 – 25,000/mm3 <25,000/mm3
<LLN – 75.0 x 10^9 /L    <75.0 – 50.0 x 10^9 /L <50.0 – 25.0 x 10^9 /L <25.0 x 10^9 /L




               Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
               beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   22
Example of Platelets Count from Local Lab to CTCAE Calculation




 CTCAE Platelets Definition
 Grade 1                     Grade 2                          Grade 3                           Grade 4

 <LLN – 75,000/mm3           <75,000 – 50,000/mm3             <50,000 – 25,000/mm3              <25,000/mm3
 <LLN – 75.0 x 10^9 /L       <75.0 – 50.0 x 10^9 /L           <50.0 – 25.0 x 10^9 /L            <25.0 x 10^9 /L



                  Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
                  beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   23
Quality Control – Additional tips in identifying Invalid Values

  For each parameter, sort the converted SI
  value in ascending order
  Review the lowest and highest values when
  are different from the expected/normal values
  by a factor of 10,100,1000
  Look for jumps in values
  Look for values that are substantially above or
  below typical normal ranges values
  Review grade 3-4 CTCAE



            Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
            beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   24
Conclusions – 1

 In many studies, laboratory data represent
 50-80% of the data to be collected
 Central laboratory are not always applicable,
 however electronical data-transfer from main
 individual laboratory used may help
 Tools (i.e. SAS macro routines), are required to
 manage and control the various steps of Local
 Laboratory Data collection and analysis
 Specialist in laboratory data-management


         Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
         beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   25
Conclusions – 2

 Estabilish a central data-repository of local labs
 How small are the differences / abnormalities
 that need to be defined?
    Choice between a more or less sophisticated
    method of harmonization of laboratory results (e.g.
    Normalization vs SI Standardization)
 CDISC LAB Team




          Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
          beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   26
Questions




        Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and
        beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007)   27

Mais conteúdo relacionado

Destaque

Local literature
Local literatureLocal literature
Local literatureNaj_Azyx
 
SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets Angelo Tinazzi
 
Efficacy endpoints in Oncology
Efficacy endpoints in OncologyEfficacy endpoints in Oncology
Efficacy endpoints in OncologyAngelo Tinazzi
 
Thesis computerized grading system
Thesis computerized grading systemThesis computerized grading system
Thesis computerized grading systemjolensreyes
 
CDISC SDTM Domain Presentation
CDISC SDTM Domain PresentationCDISC SDTM Domain Presentation
CDISC SDTM Domain PresentationAnkur Sharma
 
K-12 Grading System - Senior HS
K-12 Grading System - Senior HSK-12 Grading System - Senior HS
K-12 Grading System - Senior HSManresa School
 
Data flow diagram
Data flow diagram Data flow diagram
Data flow diagram Nidhi Sharma
 
Thesis in IT Online Grade Encoding and Inquiry System via SMS Technology
Thesis in IT Online Grade Encoding and Inquiry System via SMS TechnologyThesis in IT Online Grade Encoding and Inquiry System via SMS Technology
Thesis in IT Online Grade Encoding and Inquiry System via SMS TechnologyBelLa Bhe
 

Destaque (8)

Local literature
Local literatureLocal literature
Local literature
 
SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets SDTM modelling: from study protocol to SDTM-compliant datasets
SDTM modelling: from study protocol to SDTM-compliant datasets
 
Efficacy endpoints in Oncology
Efficacy endpoints in OncologyEfficacy endpoints in Oncology
Efficacy endpoints in Oncology
 
Thesis computerized grading system
Thesis computerized grading systemThesis computerized grading system
Thesis computerized grading system
 
CDISC SDTM Domain Presentation
CDISC SDTM Domain PresentationCDISC SDTM Domain Presentation
CDISC SDTM Domain Presentation
 
K-12 Grading System - Senior HS
K-12 Grading System - Senior HSK-12 Grading System - Senior HS
K-12 Grading System - Senior HS
 
Data flow diagram
Data flow diagram Data flow diagram
Data flow diagram
 
Thesis in IT Online Grade Encoding and Inquiry System via SMS Technology
Thesis in IT Online Grade Encoding and Inquiry System via SMS TechnologyThesis in IT Online Grade Encoding and Inquiry System via SMS Technology
Thesis in IT Online Grade Encoding and Inquiry System via SMS Technology
 

Semelhante a From Local Laboratory to Standardisation and beyond Applying a common grading system

EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...
EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...
EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...IJDKP
 
Gene Profiling in Clinical Oncology - Slide 9 - F. André - Genomic evaluation...
Gene Profiling in Clinical Oncology - Slide 9 - F. André - Genomic evaluation...Gene Profiling in Clinical Oncology - Slide 9 - F. André - Genomic evaluation...
Gene Profiling in Clinical Oncology - Slide 9 - F. André - Genomic evaluation...European School of Oncology
 
Validazione dei cfDNA Test e Controlli di Qualità Esterni e Interni
Validazione dei cfDNA Test e Controlli di Qualità Esterni e InterniValidazione dei cfDNA Test e Controlli di Qualità Esterni e Interni
Validazione dei cfDNA Test e Controlli di Qualità Esterni e InterniRoberto Scarafia
 
DISTANT-CTO: A Zero Cost, Distantly Supervised Approach to Improve Low-Resour...
DISTANT-CTO: A Zero Cost, Distantly Supervised Approach to Improve Low-Resour...DISTANT-CTO: A Zero Cost, Distantly Supervised Approach to Improve Low-Resour...
DISTANT-CTO: A Zero Cost, Distantly Supervised Approach to Improve Low-Resour...Anjani Dhrangadhariya
 
Validation of an m-Health Solution for the Follow-Up of Post-operative Patien...
Validation of an m-Health Solution for the Follow-Up of Post-operative Patien...Validation of an m-Health Solution for the Follow-Up of Post-operative Patien...
Validation of an m-Health Solution for the Follow-Up of Post-operative Patien...ITACA-TSB
 
UK-Italy dementia workshop, January 2018 - Tagliavini
UK-Italy dementia workshop, January 2018 - TagliaviniUK-Italy dementia workshop, January 2018 - Tagliavini
UK-Italy dementia workshop, January 2018 - TagliaviniUKinItaly
 
Recent advances in Tuberculosis diagnosis
Recent advances in Tuberculosis diagnosisRecent advances in Tuberculosis diagnosis
Recent advances in Tuberculosis diagnosisNishantTawari
 
2008 SPIE Photonics West
2008 SPIE Photonics West2008 SPIE Photonics West
2008 SPIE Photonics WestDanthu
 
Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
  Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...  Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...HIMSS UK
 
Digital Biomarkers for Huntington Disease
Digital Biomarkers for Huntington DiseaseDigital Biomarkers for Huntington Disease
Digital Biomarkers for Huntington DiseaseHuntington Study Group
 
Sk microfluidics and lab on-a-chip-ch6
Sk microfluidics and lab on-a-chip-ch6Sk microfluidics and lab on-a-chip-ch6
Sk microfluidics and lab on-a-chip-ch6stanislas547
 
Efficiency of Remote Technical Support for the ICD follow-up outpatients
Efficiency of Remote Technical Support for the ICD follow-up outpatientsEfficiency of Remote Technical Support for the ICD follow-up outpatients
Efficiency of Remote Technical Support for the ICD follow-up outpatientsNayaMed
 
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...Servio Fernando Lima Reina
 
PR-246: A deep learning system for differential diagnosis of skin diseases
PR-246: A deep learning system for differential diagnosis of skin diseasesPR-246: A deep learning system for differential diagnosis of skin diseases
PR-246: A deep learning system for differential diagnosis of skin diseasesSunghoon Joo
 
A Novel approach for quantitative real-time particle analysis of lentiviral v...
A Novel approach for quantitative real-time particle analysis of lentiviral v...A Novel approach for quantitative real-time particle analysis of lentiviral v...
A Novel approach for quantitative real-time particle analysis of lentiviral v...Myriade
 
Lab-on-a-Chip for cancer diagnostics and monitoring
Lab-on-a-Chip for cancer diagnostics and monitoringLab-on-a-Chip for cancer diagnostics and monitoring
Lab-on-a-Chip for cancer diagnostics and monitoringstanislas547
 
Monte Carlo And Ct Interface For Medical Treatment Plans
Monte Carlo And Ct Interface For Medical Treatment PlansMonte Carlo And Ct Interface For Medical Treatment Plans
Monte Carlo And Ct Interface For Medical Treatment Plansfondas vakalis
 

Semelhante a From Local Laboratory to Standardisation and beyond Applying a common grading system (20)

EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...
EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...
EXAMINING THE EFFECT OF FEATURE SELECTION ON IMPROVING PATIENT DETERIORATION ...
 
Gene Profiling in Clinical Oncology - Slide 9 - F. André - Genomic evaluation...
Gene Profiling in Clinical Oncology - Slide 9 - F. André - Genomic evaluation...Gene Profiling in Clinical Oncology - Slide 9 - F. André - Genomic evaluation...
Gene Profiling in Clinical Oncology - Slide 9 - F. André - Genomic evaluation...
 
Validazione dei cfDNA Test e Controlli di Qualità Esterni e Interni
Validazione dei cfDNA Test e Controlli di Qualità Esterni e InterniValidazione dei cfDNA Test e Controlli di Qualità Esterni e Interni
Validazione dei cfDNA Test e Controlli di Qualità Esterni e Interni
 
DISTANT-CTO: A Zero Cost, Distantly Supervised Approach to Improve Low-Resour...
DISTANT-CTO: A Zero Cost, Distantly Supervised Approach to Improve Low-Resour...DISTANT-CTO: A Zero Cost, Distantly Supervised Approach to Improve Low-Resour...
DISTANT-CTO: A Zero Cost, Distantly Supervised Approach to Improve Low-Resour...
 
FCRL presentation
FCRL presentationFCRL presentation
FCRL presentation
 
Validation of an m-Health Solution for the Follow-Up of Post-operative Patien...
Validation of an m-Health Solution for the Follow-Up of Post-operative Patien...Validation of an m-Health Solution for the Follow-Up of Post-operative Patien...
Validation of an m-Health Solution for the Follow-Up of Post-operative Patien...
 
UK-Italy dementia workshop, January 2018 - Tagliavini
UK-Italy dementia workshop, January 2018 - TagliaviniUK-Italy dementia workshop, January 2018 - Tagliavini
UK-Italy dementia workshop, January 2018 - Tagliavini
 
NGS and the molecular basis of disease: a practical view
NGS and the molecular basis of disease: a practical viewNGS and the molecular basis of disease: a practical view
NGS and the molecular basis of disease: a practical view
 
Recent advances in Tuberculosis diagnosis
Recent advances in Tuberculosis diagnosisRecent advances in Tuberculosis diagnosis
Recent advances in Tuberculosis diagnosis
 
2008 SPIE Photonics West
2008 SPIE Photonics West2008 SPIE Photonics West
2008 SPIE Photonics West
 
Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
  Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...  Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
Brendan Delany – Chair in Medical Informatics and Decision Making, Imperial...
 
Digital Biomarkers for Huntington Disease
Digital Biomarkers for Huntington DiseaseDigital Biomarkers for Huntington Disease
Digital Biomarkers for Huntington Disease
 
Plateforme protéomique GIGA - ULg - Lab'InSight proteomics
Plateforme protéomique GIGA - ULg - Lab'InSight proteomicsPlateforme protéomique GIGA - ULg - Lab'InSight proteomics
Plateforme protéomique GIGA - ULg - Lab'InSight proteomics
 
Sk microfluidics and lab on-a-chip-ch6
Sk microfluidics and lab on-a-chip-ch6Sk microfluidics and lab on-a-chip-ch6
Sk microfluidics and lab on-a-chip-ch6
 
Efficiency of Remote Technical Support for the ICD follow-up outpatients
Efficiency of Remote Technical Support for the ICD follow-up outpatientsEfficiency of Remote Technical Support for the ICD follow-up outpatients
Efficiency of Remote Technical Support for the ICD follow-up outpatients
 
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...
EUSFLAT 2019: explainable neuro fuzzy recurrent neural network to predict col...
 
PR-246: A deep learning system for differential diagnosis of skin diseases
PR-246: A deep learning system for differential diagnosis of skin diseasesPR-246: A deep learning system for differential diagnosis of skin diseases
PR-246: A deep learning system for differential diagnosis of skin diseases
 
A Novel approach for quantitative real-time particle analysis of lentiviral v...
A Novel approach for quantitative real-time particle analysis of lentiviral v...A Novel approach for quantitative real-time particle analysis of lentiviral v...
A Novel approach for quantitative real-time particle analysis of lentiviral v...
 
Lab-on-a-Chip for cancer diagnostics and monitoring
Lab-on-a-Chip for cancer diagnostics and monitoringLab-on-a-Chip for cancer diagnostics and monitoring
Lab-on-a-Chip for cancer diagnostics and monitoring
 
Monte Carlo And Ct Interface For Medical Treatment Plans
Monte Carlo And Ct Interface For Medical Treatment PlansMonte Carlo And Ct Interface For Medical Treatment Plans
Monte Carlo And Ct Interface For Medical Treatment Plans
 

Mais de Angelo Tinazzi

Looking for SDTM migration specialist
Looking for SDTM migration specialistLooking for SDTM migration specialist
Looking for SDTM migration specialistAngelo Tinazzi
 
Therapeutic Area Standards – Reflections on Oncology standards and what is ne...
Therapeutic Area Standards –Reflections on Oncology standards and what is ne...Therapeutic Area Standards –Reflections on Oncology standards and what is ne...
Therapeutic Area Standards – Reflections on Oncology standards and what is ne...Angelo Tinazzi
 
The PhUSE Therapeutic Area Wiki Page
The PhUSE Therapeutic Area Wiki PageThe PhUSE Therapeutic Area Wiki Page
The PhUSE Therapeutic Area Wiki PageAngelo Tinazzi
 
Interpreting CDISC ADaM IG through Users Interpretation
Interpreting CDISC ADaM IG through Users InterpretationInterpreting CDISC ADaM IG through Users Interpretation
Interpreting CDISC ADaM IG through Users InterpretationAngelo Tinazzi
 
Efficacy endpoints in Oncology
Efficacy endpoints in OncologyEfficacy endpoints in Oncology
Efficacy endpoints in OncologyAngelo Tinazzi
 
A gentle introduction to survival analysis
A gentle introduction to survival analysisA gentle introduction to survival analysis
A gentle introduction to survival analysisAngelo Tinazzi
 
A gentle introduction to meta-analysis
A gentle introduction to meta-analysisA gentle introduction to meta-analysis
A gentle introduction to meta-analysisAngelo Tinazzi
 
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...Angelo Tinazzi
 
The Implementation of ICH Development Safety Update Report (DSUR) Guidance
The Implementation of ICH Development Safety Update Report (DSUR) GuidanceThe Implementation of ICH Development Safety Update Report (DSUR) Guidance
The Implementation of ICH Development Safety Update Report (DSUR) GuidanceAngelo Tinazzi
 
THE DO’S AND DON’TS OF DATA SUBMISSION
THE DO’S AND DON’TS OF DATA SUBMISSIONTHE DO’S AND DON’TS OF DATA SUBMISSION
THE DO’S AND DON’TS OF DATA SUBMISSIONAngelo Tinazzi
 
Oncology Therapeutic Area Workshop
Oncology Therapeutic Area WorkshopOncology Therapeutic Area Workshop
Oncology Therapeutic Area WorkshopAngelo Tinazzi
 
The application of STDM in a no-profit and disease specific organisation - CD...
The application of STDM in a no-profit and disease specific organisation - CD...The application of STDM in a no-profit and disease specific organisation - CD...
The application of STDM in a no-profit and disease specific organisation - CD...Angelo Tinazzi
 

Mais de Angelo Tinazzi (13)

Adapting to Adaptive
Adapting to AdaptiveAdapting to Adaptive
Adapting to Adaptive
 
Looking for SDTM migration specialist
Looking for SDTM migration specialistLooking for SDTM migration specialist
Looking for SDTM migration specialist
 
Therapeutic Area Standards – Reflections on Oncology standards and what is ne...
Therapeutic Area Standards –Reflections on Oncology standards and what is ne...Therapeutic Area Standards –Reflections on Oncology standards and what is ne...
Therapeutic Area Standards – Reflections on Oncology standards and what is ne...
 
The PhUSE Therapeutic Area Wiki Page
The PhUSE Therapeutic Area Wiki PageThe PhUSE Therapeutic Area Wiki Page
The PhUSE Therapeutic Area Wiki Page
 
Interpreting CDISC ADaM IG through Users Interpretation
Interpreting CDISC ADaM IG through Users InterpretationInterpreting CDISC ADaM IG through Users Interpretation
Interpreting CDISC ADaM IG through Users Interpretation
 
Efficacy endpoints in Oncology
Efficacy endpoints in OncologyEfficacy endpoints in Oncology
Efficacy endpoints in Oncology
 
A gentle introduction to survival analysis
A gentle introduction to survival analysisA gentle introduction to survival analysis
A gentle introduction to survival analysis
 
A gentle introduction to meta-analysis
A gentle introduction to meta-analysisA gentle introduction to meta-analysis
A gentle introduction to meta-analysis
 
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
CLINICAL STUDY REPORT - IN-TEXT TABLES, TABLES FIGURES AND GRAPHS, PATIENT AN...
 
The Implementation of ICH Development Safety Update Report (DSUR) Guidance
The Implementation of ICH Development Safety Update Report (DSUR) GuidanceThe Implementation of ICH Development Safety Update Report (DSUR) Guidance
The Implementation of ICH Development Safety Update Report (DSUR) Guidance
 
THE DO’S AND DON’TS OF DATA SUBMISSION
THE DO’S AND DON’TS OF DATA SUBMISSIONTHE DO’S AND DON’TS OF DATA SUBMISSION
THE DO’S AND DON’TS OF DATA SUBMISSION
 
Oncology Therapeutic Area Workshop
Oncology Therapeutic Area WorkshopOncology Therapeutic Area Workshop
Oncology Therapeutic Area Workshop
 
The application of STDM in a no-profit and disease specific organisation - CD...
The application of STDM in a no-profit and disease specific organisation - CD...The application of STDM in a no-profit and disease specific organisation - CD...
The application of STDM in a no-profit and disease specific organisation - CD...
 

From Local Laboratory to Standardisation and beyond Applying a common grading system

  • 1. PhUSE Lisbon, Portugal – 8-10 October 2007 From Local Laboratory to Standardisation and beyond: Applying a commong Early Drug Development In Oncology grading system Data Management Stream (DM01) Angelo Tinazzi Data Management and Programming Unit SENDO Tech S.r.l. – Milan (ITALY) co-authors Irene Corradino, Enrica Paschetto, Sonia Colombini
  • 2. SENDO (Southern Europe New Drug Organisation) Non profit Academic Research Organisation (ARO) Early Drug Development in Oncology Coordinating a Network of oncology-hospitals 5 phase I (2 in Italy, 3 in Switzerland) ~ 30 phase II (Italy, Switzerland, Spain) Pre-clinical Laboratory (PK, PD) Head Quarter based in Milan Clinical Development Clinical Operations Data-Management Biostatistics Medical Writing Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 2
  • 3. SENDO (Southern Europe New Drug Organisation) - Partners HQ-Activities Clinical development Clinical Operation Data Center Regulatory INT, Milano Monitoring IOSI, Bellinzona, Luca Gianni Logistic Cristiana Sessa Core activities Trial design Selected Screening & MoA Clinical trials Pharmacokinetics Pharmacodynamics and also .... CHUV Lausanne, KSSG S Gallen, Istituto Mario Negri Milano Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 3
  • 4. Previous Discuss at PhUSE about Lab Data Management Szilagyi B, Binder C. Complex Laboratory Data Management, Strategies and Tools for a Way out of the Maze. PhUSE 2005; DM05 Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 4
  • 5. Laboratory Data Use of Laboratory Tests in Clinical Trials For safety Activity Categories Pharmacodynamic Pharmacokynetic Microbiology Immunology Cytology Pharmacogenomic They are also used to make immediate clinical decision for patient’s care and to define the drug profile….focus on Haematology Chemistry Urinalysis Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 5
  • 6. Laboratory Data Characteristics Qualitative vs Quantitative vs Semi-Quantitative Quantitative Most chemistry/hematology They are expressed in a specific unit They refere to a range (minimum-maximum) Semi-Quantitative (i.e. trace) Qualitative (i.e. +/-) Clinical Interpretation Not clinically significant Clinically Significant (Adverse Event) Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 6
  • 7. Laboratory Data Characteristics Focus on hematology data White Blood Count (WBC) Hemoglobin Neutrophils Monocytes Basophils Eosinophils Band Lymphocytes Platelets Red Blood Cells Hematocrit Hemoglobin Coagulation tests (i.e. PTT, PT) Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 7
  • 8. Laboratory Data Characteristics Focus on chemistry data Electrolytes Sodium Potassium Chloride Bicarbonate Carbon Dioxide They maintain body fluid and blood pressure essential for the function of most body systems Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 8
  • 9. Laboratory Data Characteristics Focus on chemistry data Enzymes Aspartate Aminotransferase (AST/SGOT) Alanine Aminotransferase (ALT/SGPT) Gamma Glutamyl Transferase (γGT) Alkaline Phosphatase Troponin I Creatine Phosphokinase (CPK) Lactate Dehydrogenase (LDH) They help diagnose liver and heart diseases Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 9
  • 10. Laboratory Data Characteristics Focus on urinalysis data Protein Cells Hormone They tests the health of organ and body process Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 10
  • 11. Laboratory Data Characteristics Normal Ranges Normal ranges, or reference ranges, are used to determine if a person’s value is “normal”. The ‘normal range’ for a given constituent of clinical interest is considered to be the concentrations of the constituent which are found in the body fluid or excretions of a group of clinically normal persons. by gender by age fasting / non-fasting analysis method / kit used by laboratory may change over time, and so the normal ranges Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 11
  • 12. Local Laboratory vs Central Laboratories Central Labs Lab samples are analysed (and taken) in the same lab center Standard methods (and machine calibration) Unique normal ranges for each sample Electronic data transfer (no data-transcription errors) Local Labs Lab samples are analysed (and taken) in different lab centers Sample can be taken anywhere / anytime Multiple normal ranges, so different methods applied No transport issue, but data need to re-keyed Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 12
  • 13. Local laboratory data-management Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 13
  • 14. Laboratory CRF – Option 1 Normal Ranges and Unit Collected directly onto patient CRF Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 14
  • 15. Laboratory CRF – Option 2 120 0 100 0 350 0 120 109/L (100-350) Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 15
  • 16. The SENDO Experience with 4 Trials Study Nr Nr. of Nr. of samples Nr. of Average Nr. of Patients collected Different Local Labs Used (average nr by Local by each Patient, min-max) Labs Used patient (min-max) 1 (ph I) 34 37 (2-90) 44 3.0 (1-7) 2 (ph I) 32 27 (2-79) 33 2.7 (1-6) 3 (ph I) 20 24 (2-61) 31 2.8 (1-5) 4 (ph II) 38 14 (2-33) 11 1.4 (1-3) Overall in 97 SENDO Repository High heterogeneity in unit reported (the example is for Platelets count only) Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 16
  • 17. Quality Control Missing data (unit, range, interpretation) Hand writing legibility Unit and value incosistencies Normal Range Validity Outliers detection Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 17
  • 18. Statistical Analysis Process Main Analysis Univariate (mean, std, min, max, etc) Shift Tables / Change From Baseline (absolute, %, log) Correlations Time to Event (i.e. Time to lowest observation, or time to nadir) Worst toxic effect observed Data must be ‘manipulated’ so that results obtained from different labs can be summed, weighted and compared Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 18
  • 19. Statistical Analysis Process Standardisation Ensures that all laboratory values are expressed in the same unit (Système International d’Unités - SI) It consists in the adoption of a standard unit by applying conversion factors Multiply 0.2558 Potassium 13.7 mg/dL SI unit is mmol/L 3.5 mmol/L Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 19
  • 20. Statistical Analysis Process Normalisation 5-29 12-35 The application of a normalisation method to ensure 10-45 homogenization of results obtained from different local 15-40 labs 12-30 U s − Ls Reference/Standard Range s = Ls + ( x − L x ) 5 U x − Lx Local Labs Range 10 Observed Value 12 12 The standard reference can be taken from the literature or from a sample of 15 normal ranges by taking the 10°and the 90°percentiles 29 30 Assume an observed value of 10 measured in the lab with normal range 5-25, if 35 our standard range has been determined to be 10-35….. 40 35 − 10 45 s = 10 + (10 − 5) = 16.25 The normalised value −5 25 Normalization. Karvanen J. DIA, Vol. 37, pp. 101-107; 2004 The statistical basis of Laboratory Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 20
  • 21. Applying a common grading system: the CTCAE NCI Common Terminology Criteria for Adverse Events – CTCAE (v3.0) A standard in oncology for classifying Adverse Events Severity A Grading system ranging from ‘0’ (no toxic effect) to ‘4’ (severe toxic effect), with the addition of ‘5’ (death) An event has unique representation Events are organised in categories Link with MedDRA Term CTCAE Event Categories Allergy / Immunology Gastrointestinal Ocular / Visual Auditor / Ear Growth and Development Pain Blood / Bone Marrow Hemorrhage / Bleeding Pulmonary / Upper Respiratory Cardiac Arrhythmia Hepatobiliary / Pancreas Renal / Genitourinary Coagulation Infection Secondary Malignancy Constitutional Symptoms Lymphatic Sexual / Reproductive Function Death Metabolic / Laboratory Surgery / Intra-Operative Injury Dermatology / Skin Musculoskeletal / Soft Tissue Syndromes Endocrine Neurology Vascular Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 21
  • 22. Applying a common grading system: the CTCAE Qualitative Definition (Arthritis) a grade 1 is defined as “Mild pain with inflammation, erythema, or joint swelling, but not interfering with function” a grade 4, is defined as “Disabling” Quantitative Definition (Diarrhea) a grade 1, is defined as “Increase of <4 stools per day over baseline; mild increase in ostomy output compared to baseline” a grade 4, is defined…. Quantitative Definition based on Lab Data Results (Platelets Count) Grade 1 Grade 2 Grade 3 Grade 4 <LLN – 75,000/mm3 <75,000 – 50,000/mm3 <50,000 – 25,000/mm3 <25,000/mm3 <LLN – 75.0 x 10^9 /L <75.0 – 50.0 x 10^9 /L <50.0 – 25.0 x 10^9 /L <25.0 x 10^9 /L Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 22
  • 23. Example of Platelets Count from Local Lab to CTCAE Calculation CTCAE Platelets Definition Grade 1 Grade 2 Grade 3 Grade 4 <LLN – 75,000/mm3 <75,000 – 50,000/mm3 <50,000 – 25,000/mm3 <25,000/mm3 <LLN – 75.0 x 10^9 /L <75.0 – 50.0 x 10^9 /L <50.0 – 25.0 x 10^9 /L <25.0 x 10^9 /L Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 23
  • 24. Quality Control – Additional tips in identifying Invalid Values For each parameter, sort the converted SI value in ascending order Review the lowest and highest values when are different from the expected/normal values by a factor of 10,100,1000 Look for jumps in values Look for values that are substantially above or below typical normal ranges values Review grade 3-4 CTCAE Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 24
  • 25. Conclusions – 1 In many studies, laboratory data represent 50-80% of the data to be collected Central laboratory are not always applicable, however electronical data-transfer from main individual laboratory used may help Tools (i.e. SAS macro routines), are required to manage and control the various steps of Local Laboratory Data collection and analysis Specialist in laboratory data-management Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 25
  • 26. Conclusions – 2 Estabilish a central data-repository of local labs How small are the differences / abnormalities that need to be defined? Choice between a more or less sophisticated method of harmonization of laboratory results (e.g. Normalization vs SI Standardization) CDISC LAB Team Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 26
  • 27. Questions Tinazzi A Corradino I Paschetto E Colombini S: From Local Laboratory to Standardisation and beyond: Applying a common grading system PhUSE 2007, DM01 (Lisbon, Portugal – 8-10 October 2007) 27